S. Jezdic

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann et al. · Annals of Oncology · 2018 · 787 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Global cancer control: responding to the growing burden, rising costs and inequalities in access

Sofía Braga, Branislav Bystrický, Camilla Qvortrup et al. · ESMO Open · 2018 · 314 citations · Full text

Public Health, Health Policy, Oncology +17

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group

Mark T.A. Donoghue, Sabrina Talukdar, Chaitanya Bandlamudi et al. · Annals of Oncology · 2019 · 238 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations

Zeid Kuzbari, Chaitanya Bandlamudi, Chey Loveday et al. · Annals of Oncology · 2022 · 135 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper

Paolo G. Casali, Paolo Bruzzi, Jan Bogaerts et al. · Annals of Oncology · 2014 · 114 citations · Full text

Medicine, Clinical Sciences, Oncology +16